Cargando…

S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

Detalles Bibliográficos
Autores principales: Kuo, K, Layton, D, Lal, A, Al-Samkari, H, Bhatia, J, Kosinski, P, Tong, B, Lynch, M, Uhlig, K, Vichinsky, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811855/
http://dx.doi.org/10.1097/01.HS9.0000821432.34545.49
_version_ 1784644521075671040
author Kuo, K
Layton, D
Lal, A
Al-Samkari, H
Bhatia, J
Kosinski, P
Tong, B
Lynch, M
Uhlig, K
Vichinsky, E
author_facet Kuo, K
Layton, D
Lal, A
Al-Samkari, H
Bhatia, J
Kosinski, P
Tong, B
Lynch, M
Uhlig, K
Vichinsky, E
author_sort Kuo, K
collection PubMed
description
format Online
Article
Text
id pubmed-8811855
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88118552022-02-22 S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA Kuo, K Layton, D Lal, A Al-Samkari, H Bhatia, J Kosinski, P Tong, B Lynch, M Uhlig, K Vichinsky, E Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8811855/ http://dx.doi.org/10.1097/01.HS9.0000821432.34545.49 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
Kuo, K
Layton, D
Lal, A
Al-Samkari, H
Bhatia, J
Kosinski, P
Tong, B
Lynch, M
Uhlig, K
Vichinsky, E
S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
title S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
title_full S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
title_fullStr S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
title_full_unstemmed S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
title_short S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
title_sort s116: long-term efficacy and safety of the oral pyruvate kinase activator mitapivat in adults with non—transfusion-dependent alpha- or beta-thalassemia
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811855/
http://dx.doi.org/10.1097/01.HS9.0000821432.34545.49
work_keys_str_mv AT kuok s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT laytond s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT lala s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT alsamkarih s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT bhatiaj s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT kosinskip s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT tongb s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT lynchm s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT uhligk s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia
AT vichinskye s116longtermefficacyandsafetyoftheoralpyruvatekinaseactivatormitapivatinadultswithnontransfusiondependentalphaorbetathalassemia